Author:
Yamamoto Takuya,Abe Tomoyuki,Oshita Akihiko,Yonehara Shuji,Katamura Yoshio,Matsumoto Nozomu,Kobayashi Tsuyoshi,Nakahara Masahiro,Ohdan Hideki,Noriyuki Toshio
Abstract
Abstract
Background
Intrahepatic cholangiocarcinoma (ICC) is the second most common malignancy of primary liver cancer. Among the several pathological types of ICC, only five cases of the clear cell type have been reported, including the one presented below. Here we report a unique case of clear cell type ICC following laparoscopic hepatectomy.
Case presentation
A 67-year-old woman had a history of hepatitis B virus. Computed tomography revealed a ring-like enhanced mass 35 mm in diameter at segment 7 in the early phase. The enhancement was prolonged to the late phase through the portal phase, while the shape was irregular. Ethoxybenzy magnetic resonance imaging revealed that the tumor had a low signal intensity on T1-weighted imaging and a high signal intensity on T2-weighted imaging. Diffusion-weighted images identified that the tumor had remarkably high signal intensity. Tumor enhancement was not detected throughout the tumor in the hepatocyte phase. Upon ICC diagnosis, a laparoscopic S7 subsegmentectomy was performed. The patient’s postoperative course was uneventful. An immunohistochemical examination revealed that the cells tested positive for cytokeratin 7 (CK7), CK19, and CD56 and negative for CK20, CD10, α-fetoprotein, thyroid transcription factor-1. At 2 years after surgery, the patient remains alive without recurrence.
Conclusions
Here we presented a case of clear cell ICC that was treated by laparoscopic hepatectomy. Immunological analysis, especially by CD56 and several CK markers, is helpful for diagnosing this disease.
Publisher
Springer Science and Business Media LLC
Reference16 articles.
1. Ercolani G, Vetrone G, Grazi G, Gian L, Aramaki O, Cescon M, et al. Intrahepatic cholangiocarcinoma: primary liver resection and aggressive multimodal treatment of recurrence significantly prolong survival. Ann Surg. 2010;252:107–14.
2. Abe T, Amano H, Shimamoto F, Hattori M, Kuroda S, Kobayashi T, et al. Prognostic evaluation of mucin-5AC expression in intrahepatic cholangiocarcinoma, mass-forming type, following hepatectomy. Eur J Surg Oncol. 2015;41:1515–21.
3. Le Roy B, Gelli M, Pittau G, Allard MA, Pereira B, Serji B, et al. Neoadjuvant chemotherapy for initially unresectable intrahepatic cholangiocarcinoma. Br J Surg. 2018;105:839–47.
4. Toriyama E, Nanashima A, Hayashi H, Abe K, Kinoshita N, Yuge S, et al. A case of intrahepatic clear cell cholangiocarcinoma. World J Gastroenterol. 2010;16:2571–6.
5. Fernandes SR, Baldaia C, Marques HP, Tortosa F, Ramalho F. Intrahepatic clear cell cholangiocarcinoma—an uncommon histologic subtype: case report and literature review. Rev Esp Enferm Dig. 2017;109:382–5.
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献